Filing Details
- Accession Number:
- 0001288123-12-000075
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-11-01 12:34:36
- Reporting Period:
- 2012-10-31
- Filing Date:
- 2012-11-01
- Accepted Time:
- 2012-11-01 12:34:36
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1098972 | Agenus Inc | AGEN | Biological Products, (No Disgnostic Substances) (2836) | 061562417 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1377202 | Shalini Sharp | C/O Agenus Inc. 111 W 57Th St., Suite 1101 New York NY 10019 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2012-10-31 | 288 | $4.40 | 80,974 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Shares sold in accordance with a Rule 10b5-1 sales plan.
Billionaire Hedge Funds
